Search research articles
Contact Us
Filters
Showing results (71-80 of 125) with videos related to
Page
of 13
Sort By:
Nature Reviews. Disease Primers
|
March 29, 2020
Colonic diverticular disease
Antonio Tursi, Carmelo Scarpignato, Lisa L Strate, et al.
Nature Reviews. Disease Primers
|
June 20, 2020
Author Correction: Colonic diverticular disease
Antonio Tursi, Carmelo Scarpignato, Lisa L Strate, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
March 10, 2019
The "DICA" endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists
Antonio Tursi, Giovanni Brandimarte, Francesco di Mario, et al.
Journal of Clinical Gastroenterology
|
September 14, 2016
Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials
Marcello Picchio, Walter Elisei, Giovanni Brandimarte, et al.
Journal of Gastroenterology and Hepatology
|
September 30, 2017
Searching for a definition for pharmacologically refractory constipation: A systematic review
Alex Yu Sen Soh, Jin-Yong Kang, Kewin Tien Ho Siah, et al.
Gastroenterology
|
December 24, 2016
Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans
Carmelo Scarpignato, Werner Dolak, Angel Lanas, et al.
Journal of Clinical Pharmacology
|
December 22, 2021
A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure
Carmelo Scarpignato, Eckhard Leifke, Neila Smith, et al.
International Journal of Clinical Pharmacy
|
March 23, 2016
Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy
Sabrina Montagnani, Marco Tuccori, Arianna Testi, et al.
Alimentary Pharmacology & Therapeutics
|
April 17, 2023
A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection
Carmelo Scarpignato, Colin W Howden, Eckhard Leifke, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 30, 2026
Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients
Darcy J Mulford, Axel Facius, Galen Witt, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 125) with videos related to
Sort By:
Page
of 13
Nature Reviews. Disease Primers
|
March 29, 2020
Colonic diverticular disease
Antonio Tursi, Carmelo Scarpignato, Lisa L Strate, et al.
Nature Reviews. Disease Primers
|
June 20, 2020
Author Correction: Colonic diverticular disease
Antonio Tursi, Carmelo Scarpignato, Lisa L Strate, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
March 10, 2019
The "DICA" endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists
Antonio Tursi, Giovanni Brandimarte, Francesco di Mario, et al.
Journal of Clinical Gastroenterology
|
September 14, 2016
Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials
Marcello Picchio, Walter Elisei, Giovanni Brandimarte, et al.
Journal of Gastroenterology and Hepatology
|
September 30, 2017
Searching for a definition for pharmacologically refractory constipation: A systematic review
Alex Yu Sen Soh, Jin-Yong Kang, Kewin Tien Ho Siah, et al.
Gastroenterology
|
December 24, 2016
Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans
Carmelo Scarpignato, Werner Dolak, Angel Lanas, et al.
Journal of Clinical Pharmacology
|
December 22, 2021
A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure
Carmelo Scarpignato, Eckhard Leifke, Neila Smith, et al.
International Journal of Clinical Pharmacy
|
March 23, 2016
Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy
Sabrina Montagnani, Marco Tuccori, Arianna Testi, et al.
Alimentary Pharmacology & Therapeutics
|
April 17, 2023
A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection
Carmelo Scarpignato, Colin W Howden, Eckhard Leifke, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 30, 2026
Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients
Darcy J Mulford, Axel Facius, Galen Witt, et al.
Page
of 13